Clinical Trials Directory

Trials / Completed

CompletedNCT03516500

Trial of Identifying the Lung Intersegmental Plane by Iron Sucrose Injection Staining

This is a Phase II Study on the Safety and Feasibility of Identifying the Intersegmental Plane of the Lung by Iron Sucrose Injection Staining,Both on the Pleural Surface and Lung Parenchyma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a protocol to determine the safety and feasibility of using Iron Sucrose Injection to identify the intersegmental plane,not only on the pleural surface but also the parenchyma of the lung.

Detailed description

This is a protocol to determine the safety and feasibility of using Iron Sucrose Injection to identify the lung intersegmental plane. This is relevant because the detection of small and early lung cancer is becoming increasingly common. segmentectomy may become a more prominent procedure for early-small lung cancer. One of the most difficult aspects of complete segmentectomy is detection of the intersegmental plane while maintaining an adequate surgical margin and remaining lung function. The method used to detect the intersegmental plane remains controversial. It is hoped that this technology can be used to recognize the intersegmental plane on the pleural surface and the pulmonary parenchyma and will save lots of money for patients in developing countries.

Conditions

Interventions

TypeNameDescription
DRUGIron Sucrose InjectionThe investigators inject Iron Sucrose (100 mg dissolved in 50 mL saline) into the segmental bronchus.

Timeline

Start date
2018-05-09
Primary completion
2021-01-21
Completion
2021-01-21
First posted
2018-05-04
Last updated
2021-08-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03516500. Inclusion in this directory is not an endorsement.